Blueprint Medicines Corp【BPMC】Cash flow
Market cap
$8.4B
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 1 | 2 | 2 | 4 | 5 | 7 | 6 | 12 | 12 | 16 |
| Stock-based compensation | 5 | 6 | 13 | 31 | 55 | 76 | 92 | 99 | 93 | 109 |
| Cash from operations | -32 | -25 | -120 | -175 | -278 | 387 | -299 | -502 | -437 | -193 |
| Capital expenditures | -5 | -2 | -16 | -13 | -14 | -3 | -3 | -9 | -16 | -5 |
| Cash from investing | -6 | -219 | -76 | -161 | -16 | -434 | -226 | -150 | 274 | -48 |
| Cash from financing | 153 | 133 | 544 | 4 | 341 | 618 | 51 | 562 | 119 | 273 |
| Free cash flow | ||||||||||
| FCF margin (%) |